Author:
Spear Timothy T.,Evavold Brian D.,Baker Brian M.,Nishimura Michael I.
Funder
National Cancer Institute
National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference68 articles.
1. Spear TT (2016) The Impact of altered T cell receptor—peptide-major histocompatibility complex interactions on antigen recognition and T cell function. Doctoral Disseration, Loyola University Chicago
2. Spear TT, Nagato K, Nishimura MI (2016) Strategies to genetically engineer T cells for cancer immunotherapy. Cancer Immunol Immunother 65:631–649.
https://doi.org/10.1007/s00262-016-1842-5
3. June CH, Maus MV, Plesa G, Johnson LA, Zhao Y, Levine BL, Grupp SA, Porter DL (2014) Engineered T cells for cancer therapy. Cancer Immunol Immunother 63:969–975.
https://doi.org/10.1007/s00262-014-1568-1
4. Casucci M, Hawkins RE, Dotti G, Bondanza A (2015) Overcoming the toxicity hurdles of genetically targeted T cells. Cancer Immunol Immunother 64:123–130.
https://doi.org/10.1007/s00262-014-1641-9
5. Morgan RA, Dudley ME, Wunderlich JR et al (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314:126–129.
https://doi.org/10.1126/science.1129003
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献